- Datum03.02.2026
- Uhrzeit12:00 - 13:00 Uhr
- Veranstalter
stock3
Vaxcyte Inc. Registered Shares DL -,001 Chart inkl. Chartanalyse
Charts analysieren
wie die Profis?
Nutze unser Profi-Charting-Tool für Deine eigenen Analysen
Chart analysieren
Vaxcyte Inc. Registered Shares DL -,001 Realtime-Kurs
| Handelsplatz | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate BSX | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
1,42 %
Intraday
0,32 %
1 Woche
15,30 %
1 Monat
16,10 %
Seit Jahresbeginn
-39,35 %
1 Jahr
17,74 %
3 Jahre
114,28 %
5 Jahre
Passender Service zu Vaxcyte Inc. Registered Shares DL -,001
Webinar zu Vaxcyte Inc. Registered Shares DL -,001
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)27,660-91,860
- Jahrestief / Hoch ($)---
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Vaxcyte Inc. Registered Shares DL -,001
Keine Dividenden verfügbar
Termine von Vaxcyte Inc. Registered Shares DL -,001
- Mär2Vaxcyte Inc. Registered Shares DL -,001Q4 2025 Earnings Release
- Mai11Vaxcyte Inc. Registered Shares DL -,001Q1 2026 Earnings Release
- Aug12Vaxcyte Inc. Registered Shares DL -,001Q2 2026 Earnings Release
Beschreibung
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company also develops VAX-XP to protect against emerging strains and address antibiotic resistance; VAX-A1, a conjugate vaccine candidate designed to treat Group A Strep; and VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.
